EFFICACY AND POSSIBLE BIOMARKER OF GEMCITABINE AND ERLOTINIB FOR ADVANCED PANCREATIC CANCER

被引：0
|
作者：
Takahashi, Hideaki [1 ]
Kuwahara, Akiko [1 ]
Okuyama, Hiroyuki [1 ]
Ohno, Izumi [1 ]
Shimizu, Satoshi [1 ]
Mitsunaga, Shuichi [1 ]
Shinohara, Akira [2 ]
Kobayashi, Misaki [2 ]
Okusaka, Takuji
Ikeda, Masafumi [1 ]
机构：
[1] Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, Japan
[2] Natl Canc Ctr Hosp East, Div Pharm, Kashiwa, Chiba, Japan
来源：
ANNALS OF ONCOLOGY | 2014年 / 25卷
关键词：
D O I：
10.1093/annonc/mdu435.87
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O2-13-4
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Efficacy of Prophylactic Minocycline Treatment for Skin Toxicities Induced by Erlotinib Plus Gemcitabine in Patients with Advanced Pancreatic Cancer: A Retrospective Study
    Akira Shinohara
    Masafumi Ikeda
    Hiroyuki Okuyama
    Misaki Kobayashi
    Hideki Funazaki
    Shuichi Mitsunaga
    Satoshi Shimizu
    Izumi Ohno
    Hideaki Takahashi
    Yasuhiko Ichida
    Kunio Takahashi
    Takuji Okusaka
    Shinichiro Saitoh
    American Journal of Clinical Dermatology, 2015, 16 : 221 - 229
  • [32] Efficacy of Prophylactic Minocycline Treatment for Skin Toxicities Induced by Erlotinib Plus Gemcitabine in Patients with Advanced Pancreatic Cancer: A Retrospective Study
    Shinohara, Akira
    Ikeda, Masafumi
    Okuyama, Hiroyuki
    Kobayashi, Misaki
    Funazaki, Hideki
    Mitsunaga, Shuichi
    Shimizu, Satoshi
    Ohno, Izumi
    Takahashi, Hideaki
    Ichida, Yasuhiko
    Takahashi, Kunio
    Okusaka, Takuji
    Saitoh, Shinichiro
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2015, 16 (03) : 221 - 229
  • [33] Erlotinib in the treatment of advanced pancreatic cancer
    Kelley, Robin K.
    Ko, Andrew H.
    BIOLOGICS-TARGETS & THERAPY, 2008, 2 (01): : 83 - 95
  • [34] First-line erlotinib and fixed dose-rate gemcitabine for advanced pancreatic cancer
    Vaccaro, Vanja
    Bria, Emilio
    Sperduti, Isabella
    Gelibter, Alain
    Moscetti, Luca
    Mansueto, Giovanni
    Ruggeri, Enzo Maria
    Gamucci, Teresa
    Cognetti, Francesco
    Milella, Michele
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (28) : 4511 - 4519
  • [35] Biweekly Gemcitabine (GEM) in Combination with Erlotinib (ERL): An Active and Convenient Regimen for Advanced Pancreatic Cancer
    Ardavanis, Alexandros
    Kountourakis, Panteleimon
    Karagiannis, Athanassios
    Doufexis, Dimitrios
    Tzovaras, Alexandros A.
    Rigatos, Gerasimos
    ANTICANCER RESEARCH, 2009, 29 (12) : 5211 - 5217
  • [36] Erlotinib, gemcitabine, paclitaxel and radiation for locally advanced pancreatic cancer: A phase I study.
    Iannitti, D
    Dipetrillo, T
    Cruff, D
    Sambandam, S
    Maia, C
    Hughes, M
    Oldenburg, N
    Thornton, K
    Kennedy, T
    Safran, H
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 336S - 336S
  • [37] A phase II study of gemcitabine, erlotinib and S-1 in patients with advanced pancreatic cancer
    Han, Boram
    Kim, Bum Jun
    Kim, Hyeong Su
    Choi, Dae Ro
    Shim, Byoung Yong
    Lee, Kyung Hee
    Kim, Jin Won
    Kim, Jung Han
    Song, Hunho
    Kim, Jong Hyeok
    Park, Choong Kee
    Lee, Jung Woo
    Kim, Min-Jeong
    Zang, Dae Young
    JOURNAL OF CANCER, 2021, 12 (03): : 912 - 917
  • [38] Prolonged complete response following gemcitabine-erlotinib combined therapy in advanced pancreatic cancer
    Czarnecka, Anna M.
    Korzen, Piotr
    Nowak-Dement, Anna
    Kukwa, Wojciech
    Korniluk, Jan
    Szczylik, Cezary
    ONCOLOGY LETTERS, 2016, 11 (02) : 1101 - 1104
  • [39] First-line erlotinib and fixed dose-rate gemcitabine for advanced pancreatic cancer
    Vanja Vaccaro
    Emilio Bria
    Isabella Sperduti
    Alain Gelibter
    Luca Moscetti
    Giovanni Mansueto
    Enzo Maria Ruggeri
    Teresa Gamucci
    Francesco Cognetti
    Michele Milella
    World Journal of Gastroenterology, 2013, (28) : 4511 - 4519
  • [40] A phase II study of isoflavone, gemcitabine, and erlotinib in locally advanced (LA) or metastatic pancreatic cancer
    Hammad, N.
    Philip, P. A.
    Shields, A. F.
    Sarkar, F. H.
    Abruzzese, J. L.
    Kaseb, A. O.
    Javle, M. M.
    Varadhachary, G. R.
    Wolff, R. A.
    El-Rayes, B. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345